Dolby Laboratories Inkomsten in het verleden
Verleden criteriumcontroles 1/6
De winst van Dolby Laboratories is gedaald met een gemiddeld jaarlijks percentage van -1.4%, terwijl de winst van de Software -industrie jaarlijks groeide met 24.9%. De inkomsten zijn groeide met een gemiddeld percentage van 1.6% per jaar. Het rendement op het eigen vermogen Dolby Laboratories bedraagt 9.3% en de nettomarge bedraagt 17.9%.
Belangrijke informatie
-1.45%
Groei van de winst
0.10%
Groei van de winst per aandeel
| Software Groei van de industrie | 17.33% |
| Inkomstengroei | 1.64% |
| Rendement op eigen vermogen | 9.34% |
| Nettomarge | 17.85% |
| Volgende winstupdate | 30 Jul 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Seeking Alpha • Jul 20
Dolby Laboratories Valuation Is Compelling Ahead Of Earnings
Summary Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x FCF and 19.7x earnings. DLB's revenue growth remains choppy, but licensing—especially in Broadcast and Mobile—drives solid results and offers mid-single-digit growth potential. Expansion into automotive and increased adoption of Dolby Atmos/Vision by major platforms and automakers support future growth, with modest price increases feasible. I expect DLB to deliver a steady, 'boring' 10% annual return, making it a solid long-term investment at current valuations. Read the full article on Seeking Alpha
Narratiefupdate • Jul 03
DLB: Streaming Partnerships And Buybacks Will Support Future Upside Potential
Analysts have reduced their fair value estimate for Dolby Laboratories from $68.00 to $60.00. They cite more conservative revenue growth assumptions and a lower future P/E multiple, partly offset by slightly stronger projected profit margins and a modestly higher discount rate.Analyse-artikel • Jun 20
Dolby Laboratories (DLB) Stock Could Be 33.2% Undervalued After Hitting A One Year Low
Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...
Narratiefupdate • Jun 18
DLB: World Cup Streaming Deal Will Support Future Share Price Recovery
Analysts have maintained their fair value estimate for Dolby Laboratories at $78.33 per share. Only minor model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions were made, resulting in an unchanged price target.Narratiefupdate • Jun 04
DLB: Immersive Content Partnerships Will Support Future Share Price Recovery
Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.Narratiefupdate • May 17
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).Narratiefupdate • May 01
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Narratiefupdate • Apr 17
DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside
Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.Narratiefupdate • Apr 03
DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook
Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).Narratiefupdate • Mar 19
DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook
Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.Narratiefupdate • Mar 05
DLB: Media Partnerships And Buybacks Will Support Measured Future Returns
Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.Narratiefupdate • Feb 19
DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns
Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.Narratiefupdate • Feb 04
DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions
Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.Analyse-artikel • Feb 02
Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...Narratiefupdate • Jan 21
DLB: Technology Adoption And Solid Execution Will Support Future Share Gains
Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.Narratiefupdate • Jan 06
DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption
Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.Analyse-artikel • Jan 05
Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?
Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...Narratiefupdate • Dec 21
DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption
Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.Narratiefupdate • Dec 07
DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds
Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.Narratiefupdate • Nov 23
DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds
Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.Analyse-artikel • Nov 11
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyse-artikel • Sep 27
Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...Narratiefupdate • Sep 06
Expanding Auto And Device Ecosystems Will Define Immersive Entertainment
Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.Analyse-artikel • Jul 28
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it had a relatively subdued...Analyse-artikel • May 27
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate
Key Insights Dolby Laboratories' estimated fair value is US$112 based on 2 Stage Free Cash Flow to Equity Dolby...Analyse-artikel • May 06
Should You Be Adding Dolby Laboratories (NYSE:DLB) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analyse-artikel • Apr 07
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it received a lot of...Analyse-artikel • Mar 23
Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Could Signal Some Risk
Dolby Laboratories, Inc.'s ( NYSE:DLB ) price-to-earnings (or "P/E") ratio of 29.6x might make it look like a strong...Analyse-artikel • Mar 10
Return Trends At Dolby Laboratories (NYSE:DLB) Aren't Appealing
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...Seeking Alpha • Feb 07
Dolby Laboratories Remains Fully Valued On Slow Growth
Summary Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely. Despite moderate growth expectations and a full stock price valuation, I maintain a Neutral rating on DLB stock due to limited upside potential. Read the full article on Seeking AlphaAnalyse-artikel • Feb 01
Dolby Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Dolby Laboratories, Inc. ( NYSE:DLB ) just released its latest first-quarter results and things are looking bullish...Analyse-artikel • Jan 26
Are Investors Undervaluing Dolby Laboratories, Inc. (NYSE:DLB) By 38%?
Key Insights The projected fair value for Dolby Laboratories is US$128 based on 2 Stage Free Cash Flow to Equity Dolby...Opbrengsten en kosten
Opbrengsten en kosten
Hoe Dolby Laboratories geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 27 Mar 26 | 1,365 | 244 | 657 | 266 |
| 26 Dec 25 | 1,339 | 241 | 645 | 264 |
| 26 Sep 25 | 1,349 | 255 | 647 | 262 |
| 27 Jun 25 | 1,347 | 264 | 640 | 263 |
| 28 Mar 25 | 1,320 | 257 | 628 | 262 |
| 27 Dec 24 | 1,315 | 263 | 625 | 263 |
| 27 Sep 24 | 1,274 | 262 | 605 | 264 |
| 28 Jun 24 | 1,259 | 212 | 605 | 265 |
| 29 Mar 24 | 1,269 | 190 | 614 | 269 |
| 29 Dec 23 | 1,280 | 188 | 615 | 274 |
| 29 Sep 23 | 1,300 | 201 | 613 | 272 |
| 30 Jun 23 | 1,287 | 219 | 603 | 263 |
| 31 Mar 23 | 1,279 | 242 | 591 | 257 |
| 30 Dec 22 | 1,237 | 183 | 617 | 257 |
| 30 Sep 22 | 1,254 | 184 | 634 | 261 |
| 01 Jul 22 | 1,261 | 201 | 639 | 261 |
| 01 Apr 22 | 1,258 | 216 | 632 | 260 |
| 31 Dec 21 | 1,243 | 255 | 587 | 259 |
| 24 Sep 21 | 1,281 | 310 | 557 | 254 |
| 25 Jun 21 | 1,267 | 293 | 541 | 253 |
| 26 Mar 21 | 1,228 | 306 | 526 | 251 |
| 25 Dec 20 | 1,260 | 318 | 538 | 245 |
| 25 Sep 20 | 1,162 | 231 | 556 | 239 |
| 26 Jun 20 | 1,189 | 248 | 554 | 238 |
| 27 Mar 20 | 1,245 | 221 | 570 | 238 |
| 27 Dec 19 | 1,231 | 206 | 560 | 237 |
| 27 Sep 19 | 1,242 | 255 | 549 | 238 |
| 28 Jun 19 | 1,183 | 238 | 550 | 238 |
| 29 Mar 19 | 1,096 | 201 | 541 | 238 |
| 28 Dec 18 | 1,057 | 193 | 525 | 239 |
| 28 Sep 18 | 1,055 | 42 | 507 | 237 |
| 29 Jun 18 | 1,056 | 37 | 490 | 234 |
| 30 Mar 18 | 1,147 | 110 | 480 | 233 |
| 29 Dec 17 | 1,115 | 95 | 474 | 232 |
| 29 Sep 17 | 1,080 | 206 | 468 | 233 |
| 30 Jun 17 | 1,072 | 204 | 464 | 235 |
| 31 Mar 17 | 1,044 | 192 | 463 | 230 |
| 30 Dec 16 | 1,051 | 208 | 458 | 224 |
| 30 Sep 16 | 1,026 | 186 | 464 | 220 |
| 01 Jul 16 | 1,025 | 208 | 470 | 211 |
| 01 Apr 16 | 980 | 180 | 470 | 202 |
| 01 Jan 16 | 977 | 171 | 467 | 206 |
| 25 Sep 15 | 971 | 181 | 461 | 201 |
Kwaliteitswinsten: DLB heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (17.9%) DLB } zijn lager dan vorig jaar (19.4%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van DLB is de afgelopen 5 jaar met 1.4% per jaar gedaald.
Versnelling van de groei: De winstgroei DLB is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.
Winst versus industrie: DLB had het afgelopen jaar een negatieve winstgroei ( -5.1% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Software ( 14.4% ).
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 9.3% ) van DLB wordt als laag beschouwd.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/07/20 20:28 |
| Aandelenkoers aan het einde van de dag | 2026/07/20 00:00 |
| Inkomsten | 2026/03/27 |
| Jaarlijkse inkomsten | 2025/09/26 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Dolby Laboratories, Inc. wordt gevolgd door 13 analisten. 4 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Vikram Kesavabhotla | Baird |
| Patrick Sholl | Barrington Research Associates, Inc. |
| Eric Wold | B. Riley Securities, Inc. |